SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-15-109443
Filing Date
2015-03-27
Accepted
2015-03-27 16:17:07
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d895369ds3.htm S-3 295161
2 EX-4.2 d895369dex42.htm EX-4.2 301009
3 EX-4.4 d895369dex44.htm EX-4.4 107550
4 EX-4.5 d895369dex45.htm EX-4.5 108634
5 EX-4.6 d895369dex46.htm EX-4.6 96867
6 EX-5.1 d895369dex51.htm EX-5.1 23941
7 EX-12.1 d895369dex121.htm EX-12.1 15780
8 EX-23.1 d895369dex231.htm EX-23.1 1483
9 GRAPHIC g895369g34e17.jpg GRAPHIC 16608
10 GRAPHIC g895369g84r98.jpg GRAPHIC 1982
  Complete submission text file 0001193125-15-109443.txt   977365
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-203072 | Film No.: 15731178
SIC: 2834 Pharmaceutical Preparations